This study will compare the efficacy and safety of mometasone furoate/formoterol fumarate (MF/F) 100/10 mcg to mometasone furoate (MF) 100 mcg, both administered twice daily (BID) by metered-dose inhaler (MDI), in 5- to 11-year-old children with persistent asthma. This study will evaluate the change in forced expiratory volume in one second (FEV1) from baseline as a measure of pulmonary function